The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle ("ovulation") derived form treated and untreated conception cycles
- PMID: 7060786
- DOI: 10.1016/s0015-0282(16)46095-4
The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle ("ovulation") derived form treated and untreated conception cycles
Abstract
A single midluteal serum progesterone concentration was obtained in 212 untreated cycles in 113 infertile patients, including 138 cycles in 72 patients in whom tubal, seminal, and cervical causes of infertility had been excluded. There were 16 conception cycles in the latter group. In an extended study a total of 21 untreated singleton conception cycles have been observed with a mean progesterone value of 40.7 nmol/l (12.8 ng/ml), 95% confidence limits of 28 to 53 nmol/l (8.8 to 16.7 ng/ml), and a range of 27 to 53 nmol/l (8.5 to 16.7 ng/ml), which extended significantly above as well as below the conception range, indicating that there is an optimal range for fertility with both an upper and a lower limit. The lower limit is of greater practical importance; and, partly to allow for assay variation, we suggest it should be taken as 30 nmol/l (9.4 ng/ml). It provided a clinically reliable criterion of potential fertility ("ovulation") in related studies. Our findings in treated conception cycles suggest that a higher value may be needed after treatment with clomiphene or gonadotropins because of the contribution from other stimulated follicles.
Similar articles
-
Single midluteal progesterone assay in the management of ovulatory infertility.J Reprod Med. 1981 Feb;26(2):85-9. J Reprod Med. 1981. PMID: 7218223
-
Clomiphene citrate therapy of infertile women with low luteal phase progesterone levels.Obstet Gynecol. 1982 Mar;59(3):275-9. Obstet Gynecol. 1982. PMID: 7078874
-
Single luteal phase serum progesterone assay as an indicator of ovulation.Am J Obstet Gynecol. 1972 Apr 15;112(8):1043-6. doi: 10.1016/0002-9378(72)90178-0. Am J Obstet Gynecol. 1972. PMID: 5017634
-
Luteal phase evaluation after clomiphene-chorionic gonadotrophin-induced ovulation.Int J Fertil. 1983;28(2):104-6. Int J Fertil. 1983. PMID: 6136471
-
Luteal phase defects.J Reprod Med. 1993 May;38(5):348-56. J Reprod Med. 1993. PMID: 8320670 Review.
Cited by
-
HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels - a proof of concept.J Ovarian Res. 2014 Apr 3;7:35. doi: 10.1186/1757-2215-7-35. J Ovarian Res. 2014. PMID: 24694069 Free PMC article.
-
Preparation of the endometrium for frozen embryo transfer: an update on clinical practices.Reprod Biol Endocrinol. 2023 Jun 8;21(1):52. doi: 10.1186/s12958-023-01106-5. Reprod Biol Endocrinol. 2023. PMID: 37291605 Free PMC article. Review.
-
The effect of rifampin on serum etonogestrel concentrations and biomarkers of ovulation among contraceptive implant users: A pharmacokinetic and pharmacodynamic study.Contraception. 2023 Jul;123:110035. doi: 10.1016/j.contraception.2023.110035. Epub 2023 Mar 28. Contraception. 2023. PMID: 36997081 Free PMC article.
-
Anovulatory and ovulatory infertility: results with simplified management.Br Med J (Clin Res Ed). 1982 Jun 5;284(6330):1681-5. doi: 10.1136/bmj.284.6330.1681. Br Med J (Clin Res Ed). 1982. PMID: 6805656 Free PMC article.
-
Elinzanetant (NT-814), a Neurokinin 1,3 Receptor Antagonist, Reduces Estradiol and Progesterone in Healthy Women.J Clin Endocrinol Metab. 2021 Jul 13;106(8):e3221-e3234. doi: 10.1210/clinem/dgab108. J Clin Endocrinol Metab. 2021. PMID: 33624806 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical